401 filings
Page 5 of 21
8-K
a2nr0fekr cd8kxh9mz
2 Jun 08
Other Events
12:00am
8-K
j8lm 6iez1tjvz1am4x0
2 Jun 08
Erbitux® (Cetuximab) Data Demonstrate Improved Overall Survival In First-line Treatment of Advanced Non-small Cell Lung Cancer
12:00am
8-K
8giv0r ccm
2 Jun 08
Imclone Appoints DR. Bernhard Ehmer Senior Vice President and Managing Director, International Operations
12:00am
8-K
zyr45yizcj46 79a3
16 May 08
Departure of Directors or Principal Officers
12:00am
8-K
hxvhb
16 May 08
Erbitux® (Cetuximab) Data Demonstrate Improvements
12:00am
8-K
sdvun bm6snv6pfun
2 May 08
Departure of Directors or Principal Officers
12:00am
8-K
qeqo33np0s3 u4fj
24 Apr 08
Imclone Systems Reports First Quarter 2008 Financial Results
12:00am
8-K
bu1v8vb
23 Apr 08
Imclone Announces Agreement with Fda on Special Protocol
12:00am
8-K
zo3lt8itr4 pr
31 Mar 08
Imclone Appoints Kenneth J. Zuerblis Chief Financial Officer
12:00am
UPLOAD
jblnt20xn5v
1 Feb 08
Letter from SEC
12:00am
CORRESP
l7n0igudh
1 Feb 08
Correspondence with SEC
12:00am
8-K
a07vrucvp6 6n2ntxxpv
31 Jan 08
Imclone Systems Reports Fourth Quarter and Full Year 2007
12:00am
UPLOAD
e09lejf3uu rswmh6z
25 Jan 08
Letter from SEC
12:00am
UPLOAD
dhl0v t9jhu
18 Jan 08
Letter from SEC
12:00am
8-K
p48eg
11 Jan 08
Departure of Directors or Principal Officers
12:00am
8-K
5tqw3liyk86et
14 Dec 07
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
jtf0ube
13 Dec 07
Imclone and Sanofi-aventis Settle Patent Litigation with Yeda Research and Development Corporation
12:00am